Eyenovia announces $15 million credit facility with avenue venture debt fund

Transaction proceeds, together with cash on-hand, expected to fund operations through late 2023/early 2024, including potential fda approval of mydcombi™ transaction proceeds, together with cash on-hand, expected to fund operations through late 2023/early 2024, including potential fda approval of mydcombi™
EYEN Ratings Summary
EYEN Quant Ranking